The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Oncology Impact Fund (cayman) Management L.p. since 2020.
This trader's CIK number is 1721036.
At the time of last reporting, Oncology Impact Fund (cayman) Management L.p. was the 10% Owner of Iteos Therapeutics, Inc.. (stock ticker symbol ITOS).
Also see all insider trading activities at Iteos Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | ITOS | 0 | $0 | 245,469 | $10,796,783 | 0 | $0 |
| 2021 | ITOS | 0 | $0 | 1,227,160 | $37,086,388 | 0 | $0 |
| 2020 | ITOS | 320,000 | $6,080,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-01-04 | ITOS | Sale | 215,122 | 44.26 | 9,521,299 |
| 2022-01-05 | ITOS | Sale | 30,347 | 42.03 | 1,275,484 |
| 2021-12-03 | ITOS | Sale | 33,749 | 35.46 | 1,196,739 |
| 2021-12-06 | ITOS | Sale | 17,083 | 33.76 | 576,722 |
| 2021-12-07 | ITOS | Sale | 32,558 | 33.63 | 1,094,925 |
| 2021-12-02 | ITOS | Sale | 62,230 | 34.28 | 2,133,555 |
| 2021-11-30 | ITOS | Sale | 56,801 | 34.91 | 1,982,638 |
| 2021-12-01 | ITOS | Sale | 20,742 | 34.59 | 717,465 |
| 2021-11-26 | ITOS | Sale | 21,210 | 35.76 | 758,469 |
| 2021-11-29 | ITOS | Sale | 17,356 | 34.91 | 605,984 |
| 2021-11-24 | ITOS | Sale | 60,808 | 36.09 | 2,194,560 |
| 2021-11-23 | ITOS | Sale | 33,476 | 36.35 | 1,217,019 |
| 2021-11-22 | ITOS | Sale | 35,333 | 37.48 | 1,324,457 |
| 2021-10-18 | ITOS | Sale | 10,320 | 27.14 | 280,084 |
| 2021-10-15 | ITOS | Sale | 18,295 | 27.77 | 508,052 |
| 2021-10-12 | ITOS | Sale | 14,260 | 27.09 | 386,303 |
| 2021-10-13 | ITOS | Sale | 35,023 | 27.13 | 950,173 |
| 2021-10-14 | ITOS | Sale | 45,719 | 27.30 | 1,248,128 |
| 2021-10-07 | ITOS | Sale | 1,922 | 27.00 | 51,894 |
| 2021-10-08 | ITOS | Sale | 3,400 | 27.01 | 91,834 |
| 2021-10-11 | ITOS | Sale | 81,684 | 27.24 | 2,225,072 |
| 2021-10-04 | ITOS | Sale | 34,659 | 27.06 | 937,872 |
| 2021-10-01 | ITOS | Sale | 11,471 | 27.00 | 309,717 |
| 2021-09-28 | ITOS | Sale | 32,154 | 27.00 | 868,158 |
| 2021-09-30 | ITOS | Sale | 3,836 | 27.00 | 103,572 |
| 2021-09-27 | ITOS | Sale | 19,455 | 27.09 | 527,035 |
| 2021-09-24 | ITOS | Sale | 8,221 | 27.81 | 228,626 |
| 2021-09-23 | ITOS | Sale | 61,800 | 28.17 | 1,740,906 |
| 2021-09-21 | ITOS | Sale | 32,858 | 27.47 | 902,609 |
| 2021-09-22 | ITOS | Sale | 23,921 | 27.54 | 658,784 |
| 2021-09-20 | ITOS | Sale | 40,673 | 27.43 | 1,115,863 |
| 2021-09-17 | ITOS | Sale | 76,473 | 28.82 | 2,203,951 |
| 2021-09-16 | ITOS | Sale | 35,565 | 28.47 | 1,012,535 |
| 2021-09-14 | ITOS | Sale | 36,081 | 27.75 | 1,001,067 |
| 2021-09-15 | ITOS | Sale | 40,336 | 27.97 | 1,128,197 |
| 2021-09-09 | ITOS | Sale | 38,028 | 28.97 | 1,101,671 |
| 2021-09-10 | ITOS | Sale | 22,643 | 28.30 | 640,683 |
| 2021-09-13 | ITOS | Sale | 35,785 | 27.64 | 989,097 |
| 2021-09-07 | ITOS | Sale | 50,996 | 29.18 | 1,488,063 |
| 2021-09-08 | ITOS | Sale | 20,236 | 28.86 | 583,909 |
| 2020-07-28 | ITOS | Buy | 320,000 | 19.00 | 6,080,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Oncology Impact Fund (cayman) Management L.p. (10% Owner of Iteos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.